The aging gut presents one of medicine's most pressing puzzles: how does intestinal decline contribute to systemic aging, and can we meaningfully intervene? New primate research reveals that a specific protein regulator, NCoR1, consistently drops with age across intestinal cells—and that metformin can restore these levels while delaying broader intestinal aging processes. Using single-nucleus sequencing technology on nonhuman primate intestinal tissue, investigators mapped cellular changes across the aging gut with unprecedented precision. They documented barrier dysfunction that allows harmful substances to leak into circulation, chronic inflammation that accelerates tissue damage, and stem cell fate bias where regenerative capacity becomes skewed and less effective. Most significantly, they identified declining levels of Nuclear Receptor Corepressor 1 (NCoR1) as a conserved aging signature across multiple intestinal cell types. This finding bridges decades of research on metabolic regulation and cellular aging. NCoR1 functions as a master regulator of gene expression, particularly genes involved in metabolism and inflammation control. Its decline during aging may explain why intestinal barrier function deteriorates and inflammatory responses become dysregulated. The metformin intervention data proves especially compelling because it demonstrates reversibility—aging changes aren't necessarily permanent cellular scars. When older primates received metformin treatment, NCoR1 levels increased toward youthful ranges, accompanied by improved barrier function and reduced inflammatory markers. This represents more than incremental progress in aging research. The primate model provides crucial translational relevance that rodent studies cannot offer, given the closer evolutionary relationship to human intestinal physiology. The NCoR1-metformin connection also suggests that existing diabetes medications may have broader anti-aging applications through mechanisms beyond glucose control, potentially opening new therapeutic strategies for age-related intestinal dysfunction.